Rebecca has worked with ERP and MES systems and NN global supply chain for + 15 years. She was a business process specialist and super user of SAP, before she became a Solution Architect on a global ERP/MES implementation for all NN production sites (+20 sites). Currently, she is the MES System Architect and member of the leadership team in NN MES CoE, where she sets boundaries and direction for the MES functionality and solution. She is a member of BioPhorum’s MES of the Future work stream since 2022 and contributor to white papers regarding Interfaces and data. She is a passionate music lover, a mother of two, and hobby chef and visual artist.
I’m a visionary who is intrigued by the technological developments in the MES arena and how we in the industry can adopt and benefit from these developments. I’m a tech sceptic and I do not get swept away by tech fads as I want to understand and analyse how the adaptation can help us move forward. I’m fascinated by the human and organizational change that follows digitalization and technology transfer, and I’m passionate about enabling the human creativity by using IT and OT systems.

With more than 10 years of experience as an MES/PCS Specialist at Novo Nordisk, Kenn Egholm has established a reputation for excellence in the field. Prior to joining Novo Nordisk, he served as an IT Consultant at NNE Pharmaplan, where he contributed to the development and implementation of cutting-edge technological solutions. Kenn Egholm holds a Bachelor's degree in Electrical Engineering from the Technical University of Denmark, providing a solid foundation for his work in complex systems integration.

We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 55,000 people in 80 offices around the world, and market our products in 170 countries.

We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 55,000 people in 80 offices around the world, and market our products in 170 countries.